Business / Finance

RSS

GNC Holdings reports consolidated revenue of $607.2 million for fourth quarter 2014

GNC Holdings, Inc., a leading global specialty retailer of health and wellness products, today reported its financial results for the quarter and year-to-date periods ended December 31, 2014.

12 Feb 2015

Transition Therapeutics commences underwritten public offering of common shares

Transition Therapeutics Inc. announced today that it has commenced an underwritten public offering of its common shares.

12 Feb 2015

SRI Biosciences awarded contract to develop novel polymers to neutralize chemical, biological threats

SRI Biosciences, a division of SRI International, has been awarded a $10 million contract under a DARPA program to reimagine how proteins are constructed and to develop novel medicines and diagnostics as countermeasures to chemical and biological threats.

12 Feb 2015

Resource Ventures announces corporate update, anticipates record annual revenues

Resource Ventures, Inc. Interim President Michael Cipolla is pleased to announce today that the company anticipates reporting record annual revenues.

12 Feb 2015

Epicore BioNetworks named one of 50 strongest companies on TSXV

Epicore BioNetworks Inc. is proud to announce that the Company has been selected by TSX Venture 50 as one of the 50 strongest companies on the TSXV.

12 Feb 2015

World Courier opens new distribution facility in Melbourne, Australia

World Courier, the global leader in specialty logistics and an AmerisourceBergen company, has opened the doors to its new distribution facility in Melbourne, Australia.

12 Feb 2015

ADDF, Pfizer's CTI collaborate to advance development of new drugs for Alzheimer's disease

The Alzheimer's Drug Discovery Foundation and Pfizer's Centers for Therapeutic Innovation announced today a collaboration designed to advance the development of new small-molecule drugs for Alzheimer's disease and related dementias. As part of the first-of-its kind collaboration in Alzheimer's, the ADDF and CTI will jointly invest in translational research projects, with a focus on novel Alzheimer's drug targets.

11 Feb 2015

GBUK take whole group approach to medical device industry accreditation

The MIA credentialing scheme was launched in 2013 by the medical technology industry to raise training standards for company representatives and service engineers visiting acute and critical care areas of hospitals.

11 Feb 2015

Henry Schein's net sales increase 7.0% to $2.7 billion in fourth quarter 2014

Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today reported record financial results for the fourth quarter.

11 Feb 2015

Jefferson, RMA of Philadelphia announce clinical partnership

Jefferson announced today its clinical partnership with RMA of Philadelphia, merging the expertise of two outstanding groups of reproductive specialists on its Center City campus.

11 Feb 2015

Psychemedics' revenue increases 4% to $6.8 million in fourth quarter 2014

Psychemedics Corporation today announced fourth quarter and year-end financial results for the period ended December 31, 2014. The Company also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of February 23, 2015 to be paid on March 6, 2015. This will be the Company's 74th consecutive quarterly dividend.

11 Feb 2015

UM one step closer to developing potential drug for treating brain cancer

Promentis Pharmaceuticals, Inc. recently announced it will enter an exclusive agreement with UM to commercialize a discovery made by a team of UM faculty scientists that has the potential to treat brain cancer and possibly other disorders of the central nervous system.

11 Feb 2015

Kaiser denies Prime Healthcare claims over purchase of Daughters of Charity Health System

In a bizarre announcement, Prime Healthcare said Monday that Kaiser Permanente was now supporting its purchase of Daughters of Charity Health System, a claim that Kaiser has unequivocally denied.

11 Feb 2015

DePuy Synthes announces acquisition of Olive Medical

Today DePuy Synthes Companies announced that it has acquired Olive Medical Corporation, a Utah-based privately held provider of high definition (HD) visualization systems for minimally invasive surgery (MIS). Financial terms of the transaction were not disclosed.

10 Feb 2015

Pfenex, Hospira sign agreement to develop and commercialize LUCENTIS biosimilar

Pfenex Inc., a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, and Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today announced that the companies have entered into an agreement to exclusively develop and commercialize for worldwide sales PF582, Pfenex's biosimilar candidate to Genentech's LUCENTIS (ranibizumab injection).

10 Feb 2015

Bayer materials withstand demanding conditions and meet requirements for innovative medical devices MD&M West

Increasingly, innovative medical applications place further importance on the success of the materials they use. When patients’ health, mobility and comfort are involved, reliability and durability are crucial. Bayer MaterialScience LLC steps up to the challenge offering original equipment manufacturers (OEMs) a wide range of material solutions for their medical application needs.

10 Feb 2015

Isis receives $5 million from Biogen Idec to develop drugs for neurological disorders

Isis Pharmaceuticals, Inc. announced today it has earned a $5 million milestone payment from Biogen Idec associated with the validation of an undisclosed target to treat a neurological disorder under its broad strategic collaboration with Biogen Idec to develop drugs to treat patients with neurological disorders.

10 Feb 2015

PBI announces receipt of first purchase order for new Barozyme HT48 High-throughput System

Pressure BioSciences, Inc., a leader in the development and sale of broadly enabling sample preparation solutions using pressure cycling technology ("PCT")-based instruments and consumables to the worldwide life sciences industry, today announced the receipt of the first purchase order for its new Barozyme HT48 High-throughput System.

10 Feb 2015

Quest Diagnostics, Myriad Genetics reach agreement to end BRCA gene-patent litigation

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it and Myriad Genetics Inc. have reached an agreement that ends their BRCA gene-patent litigation.

From Quest Diagnostics 10 Feb 2015

Roche announces acquisition of Signature Diagnostics

Roche announced today the acquisition of Signature Diagnostics AG, a privately held company based in Potsdam, Germany. Signature is a translational oncology and genomics company that develops large blood plasma and tissue biobanks in multiple cancers, including colorectal and lung, which are constructed from multicenter prospective clinical studies.

From Roche Sequencing and Life Science 10 Feb 2015

Business / Finance

GNC Holdings reports consolidated revenue of $607.2 million for fourth quarter 2014

Transition Therapeutics commences underwritten public offering of common shares

SRI Biosciences awarded contract to develop novel polymers to neutralize chemical, biological threats

Resource Ventures announces corporate update, anticipates record annual revenues

Epicore BioNetworks named one of 50 strongest companies on TSXV

World Courier opens new distribution facility in Melbourne, Australia

ADDF, Pfizer's CTI collaborate to advance development of new drugs for Alzheimer's disease

GBUK take whole group approach to medical device industry accreditation

Henry Schein's net sales increase 7.0% to $2.7 billion in fourth quarter 2014

Jefferson, RMA of Philadelphia announce clinical partnership

Psychemedics' revenue increases 4% to $6.8 million in fourth quarter 2014

UM one step closer to developing potential drug for treating brain cancer

Kaiser denies Prime Healthcare claims over purchase of Daughters of Charity Health System

DePuy Synthes announces acquisition of Olive Medical

Pfenex, Hospira sign agreement to develop and commercialize LUCENTIS biosimilar

Bayer materials withstand demanding conditions and meet requirements for innovative medical devices MD&M West

Isis receives $5 million from Biogen Idec to develop drugs for neurological disorders

PBI announces receipt of first purchase order for new Barozyme HT48 High-throughput System

Quest Diagnostics, Myriad Genetics reach agreement to end BRCA gene-patent litigation

Roche announces acquisition of Signature Diagnostics

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News